Last 1,744 GBp
Change Today -26.00 / -1.47%
Volume 267.3K
As of 11:35 AM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for hikma pharmaceuticals plc (HIK)

Year over year, Hikma Pharmaceuticals plc has been able to grow revenues from $1.1B USD to $1.4B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 56.27% to 47.47%. This was a driver that led to a bottom line growth from $100.0M USD to $212.0M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
Dec 31
2011
Reclassified
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
Revenues730.9918.01,109.01,365.0
TOTAL REVENUES730.9918.01,109.01,365.0
Cost of Goods Sold386.7534.9624.0648.0
GROSS PROFIT344.3383.1485.0717.0
Selling General & Admin Expenses, Total183.7232.8273.0311.0
R&D Expenses23.631.234.031.0
Other Operating Expenses-4.80.31.0-20.0
OTHER OPERATING EXPENSES, TOTAL202.5264.3308.0322.0
OPERATING INCOME141.8118.7177.0395.0
Interest Expense-6.0-13.8-22.0-22.0
Interest and Investment Income0.30.51.01.0
NET INTEREST EXPENSE-5.6-13.3-21.0-21.0
Income (Loss) on Equity Investments---1.21.0-3.0
Currency Exchange Gains (Loss)-6.3-0.1-3.02.0
Other Non-Operating Income (Expenses)-8.5-10.3-15.0-14.0
EBT, EXCLUDING UNUSUAL ITEMS121.393.8139.0359.0
Merger & Restructuring Charges-7.7------
Gain (Loss) on Sale of Investments7.2-----16.0
Gain (Loss) on Sale of Assets0.20.1----
Other Unusual Items, Total-----7.0-45.0
Other Unusual Items-----7.0-35.0
EBT, INCLUDING UNUSUAL ITEMS121.093.9132.0298.0
Income Tax Expense21.510.425.082.0
Minority Interest in Earnings-0.7-3.4-7.0-4.0
Earnings from Continuing Operations99.583.5107.0216.0
NET INCOME98.880.1100.0212.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS98.880.1100.0212.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS98.880.1100.0212.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HIK:LN 1,744.00 GBp -26.00

HIK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hospira Inc $54.24 USD +0.20
View Industry Companies
 

Industry Analysis

HIK

Industry Average

Valuation HIK Industry Range
Price/Earnings 18.7x
Price/Sales 3.9x
Price/Book 5.0x
Price/Cash Flow 18.6x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HIKMA PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.